AIM: To investigate the role of Ras association domain family protein 1 isoform A (RASSF1A) in gastric tumorigenesis. METHODS: Through over-expression of RASSF1A gene in the SGC7901 cell line which was induced by a lipofectamine-mediated gene transfer approach. Activator protein-1 (AP-1) DNA binding activity was measured by electrophoretic mobility shift assay (EMSA). RESULTS: Compared with the control clones, cells over-expressing RASSF1A exhibited significant inhibition of cell growth with G1 cell cycle arrest in vitro and in vivo. The over-expression of RASSF1A significantly inhibited AP-1 activity in SGC7901 cells (0.981+/-0.011 vs 0.354+/-0.053, P<0.001). In addition, both Western blot analysis and immunocytochemistry demonstrated that RASSF1A down-regulated the expression of c-Fos (0.975+/-0.02 vs 0.095+/-0.024, P<0.001) but not c-Jun. CONCLUSION: Over-expression of RASSF1A inhibits the growth of SGC7901 cells by negatively regulating the AP-1 activity, the latter in turn negatively signals cell proliferation.
AIM: To investigate the role of Ras association domain family protein 1 isoform A (RASSF1A) in gastric tumorigenesis. METHODS: Through over-expression of RASSF1A gene in the SGC7901 cell line which was induced by a lipofectamine-mediated gene transfer approach. Activator protein-1 (AP-1) DNA binding activity was measured by electrophoretic mobility shift assay (EMSA). RESULTS: Compared with the control clones, cells over-expressing RASSF1A exhibited significant inhibition of cell growth with G1 cell cycle arrest in vitro and in vivo. The over-expression of RASSF1A significantly inhibited AP-1 activity in SGC7901 cells (0.981+/-0.011 vs 0.354+/-0.053, P<0.001). In addition, both Western blot analysis and immunocytochemistry demonstrated that RASSF1A down-regulated the expression of c-Fos (0.975+/-0.02 vs 0.095+/-0.024, P<0.001) but not c-Jun. CONCLUSION: Over-expression of RASSF1A inhibits the growth of SGC7901 cells by negatively regulating the AP-1 activity, the latter in turn negatively signals cell proliferation.
Authors: Sara Ortiz-Vega; Andrei Khokhlatchev; Maria Nedwidek; Xian-feng Zhang; Reinhard Dammann; Gerd P Pfeifer; Joseph Avruch Journal: Oncogene Date: 2002-02-21 Impact factor: 9.867
Authors: C Sakakura; T Mori; T Sakabe; Y Ariyama; T Shinomiya; K Date; A Hagiwara; T Yamaguchi; T Takahashi; Y Nakamura; T Abe; J Inazawa Journal: Genes Chromosomes Cancer Date: 1999-04 Impact factor: 5.006
Authors: Xiao-Hua Jiang; Shui-Ping Tu; Jian-Tao Cui; Marie C M Lin; Harry H X Xia; Wai Man Wong; Annie On-On Chan; Man Fung Yuen; Shi-Hu Jiang; Shiu-Kum Lam; Hsiang-Fu Kung; Jae Won Soh; I Bernard Weinstein; Benjamin Chun-Yu Wong Journal: Cancer Res Date: 2004-08-15 Impact factor: 12.701
Authors: Angelo Agathanggelou; Ivan Bièche; Jalal Ahmed-Choudhury; Barbara Nicke; Reinhard Dammann; Shairaz Baksh; Boning Gao; John D Minna; Julian Downward; Eamonn R Maher; Farida Latif Journal: Cancer Res Date: 2003-09-01 Impact factor: 12.701
Authors: Igor Kuzmin; John W Gillespie; Alexei Protopopov; Laura Geil; Koen Dreijerink; Youfeng Yang; Cathy D Vocke; Fuh-Mei Duh; Eugene Zabarovsky; John D Minna; Johng S Rhim; Michael R Emmert-Buck; W Marston Linehan; Michael I Lerman Journal: Cancer Res Date: 2002-06-15 Impact factor: 12.701